Introduction
The cyclin-dependent kinases (CDKs) are regulatory enzymes that initiate and coordinate events of the eukaryotic cell cycle (for reviews see Norbury and Nurse, 1992; Morgan, 1995) . Phosphorylation of a conserved threonine residue in the catalytic subunit is required for activation of all known CDKs. The enzyme responsible for this modification, the CDK-activating kinase (CAK), has recently been identified and characterized in several species. Molecular cloning of two CAK subunits revealed that CAK is itself a cyclin-dependent kinase composed of a catalytic subunit, CDK7, and a positive regulatory subunit, cyclin H (Fesquet et al., 1993; Poon et al., 1993; Solomon et al., 1993; Fisher and Morgan, 1994; Makela et al., 1994) . The reconstituted enzyme phosphorylates and activates complexes of CDCP (CDKl) and CDK2 with various cyclins Makela et al., 1994) , as well as CDK4-cyclin D2 complexes . The activation of one CDK by another suggested the existence of a CDK cascade effecting cell cycle transitions. Consistent with this model, CDK7 itself required an activating threonine residue (T170 in human CDK7) for reconstitution of full enzymatic activity in vitro Labbe et al., 1994; Poon et al., 1994) perhaps reflecting a dependence of CDK7-cyclin H binding on T170 phosphorylation (Makela et al., 1994) .
Analyses of CAK activity and CDK7 protein (Brown et al., 1994; Matsuoka et al., 1994; Poon et al., 1994; Tassan et al., 1994) and of cyclin H protein (H. M. C. and D. 0. M., unpublished data) revealed essentially constant levels throughout the cell cycle and led to the conclusion that activating phosphorylation by CAK may not be rate-limiting in vivo, at least under the conditions (and for the CDK targets) tested Tassan et al., 1994) . On the other hand, the demonstration that CAK is an essential component of the transcription-DNA repair factor TFIIH (Roy et al., 1994; Serizawa et al., 1995; Shiekhattar et al., 1995) makes such measurements more difficult to interpret. CAK probably exists in both TFIIH-bound and unbound forms (Roy et al., 1994; Shiekhattar et al., 1995) that may be regulated differently; entry into or exit from the TFIIH complex could be a regulatory mechanism in itself.
In this report, we show that CAK purified from mouse tissue culture cells contains three polypeptides in apparently equimolar amounts: CDK7, cyclin H, and a novel polypeptide of -36 kDa (~36). CAK purified by immunoaffinity from human cells with antibodies against CDK7 , or against cyclin H, shows a similar threesubunit composition.
We have cloned a mouse cDNA encoding ~36; the sequence contains a C3HC4 zincbinding domain near its amino terminus and a central region with the potential to form a coiled coil. p36 is present in both a soluble -175 kDa form of CAK and in a -650 kDa TFIIH-associated form. Purified p36 promotes stable binding of CDK7 and cyclin H and circumvents the need for T170 phosphorylation; CDK7-cyclin H-p36 complexes bearing a mutation of T170 to alanine (T170A) are fully active. Conversely, phosphorylation of T170 obviates the requirement for p36 both in vivo and in vitro, allowing assembly of active CDK7-cyclin H binary complexes. Thus, CAK may be assembled and activated through two potentially independent pathways, depending on the availability and activity of the assembly factor ~36, an activating kinase, or both.
Results

Purification
of Three-Subunit CAK and Identification of a Novel Subunit We previously described the purification of CAK from mammalian cell extracts by conventional chromatographies . In some CAK preparations from HeLa cells, the final enzyme fraction contained only two major polypeptides, CDK7 and cyclin H. In contrast, purification of CAK from mouse 3T3 cell extracts by a similar scheme consistently resulted in the copurification with CAK activity ( Figure 1A ) of three polypeptides of apparentlyequal abundance (Figure 1 B) . In addition toCDK7 and cyclin H, the purified enzyme contained a third polypeptide with an apparent molecularweight of 36 kDa(p36). In preparative polyacrylamide gels, cyclin H and p36 comigrated (see Figure 2C of Fisher and Morgan, 1994) . We therefore subjected a mixture of the two polypeptides to tryptic peptide sequencing, which yielded four peptides that were not derived from cyclin H. We used degenerate which were washed and tested for the ability to phosphorylate histone Hl (indicated at left). (6) Polypeptidecompositionof purified mouseCAK. HiTrapQfractions (10 ~1 or 11100 of total) were electrophoresed in a 10% polyacrylamide gel, and polypeptides were visualized by silver staining. The positions of molecular weight markers are shown at left. Also indicated at left are the positions of the three CAK subunits: CDK7, cyclin H, and ~36. polymerase chain reaction (PCR) to amplify a 451 bp fragment, which we in turn used to isolate the full-length ~36 cDNA from a mouse library. The -1.4 kb cDNA contains an open reading frame of 309 amino acids that potentially encodes a polypeptide with a predicted molecular weight of 35.8 kDa ( Figure 2A ). All four p36 peptides are present in the open reading frame.
CAK p36 Is a Novel RING Finger Protein A search of the GenBank database revealed no extensive homologies with known proteins. However, p36 contains a recently defined structural motif, the C3HC4 zinc-binding domain or RING finger (reviewed by Freemont, 1993) . An alignment of p36 with several representative RING domains ( Figure 28 ) revealed perfect conservation of the metal-ligating cysteine and histidine residues. Also conserved is the location of the RING finger near the amino terminus of ~36. No other obvious structural motifs were found, although a central region of the protein is predicted to form a coiled coil (Figure 2A ; Lupas et al., 1991) and shows limited homologies with other coiled-coil proteins.
p36 Is a Component of CAK-TFIIH Complexes CDK7 and cyclin H are associated with the RNA polymerase II general transcription factor TFIIH (Roy et al., 1994; Serizawa et al., 1995; Shiekhattar et al., 1995) . To determine whether p36 was also associated with TFIIH, we frac- The sequence of peptide 1 actually began with an aspartate residue, instead of the glutamic acid predicted by the cDNA sequence. The metal-coordinating residues of the CSHCl domain are denoted by bold typeface and asterisks. A region predicted to formed coiled-coil structure (amino acids 90-180) is indicated by the double underline. (B) Alignment of the p36 RING finger with other family members. The conserved metal-ligating residues are in bold typeface. Proteins listed are as follows: SS-A/Ro (Chan et al., 1991) RPT-1 (Patarca et al., 1988) XNF7 (Reddy et al., 1991) PML (Goddard et al., 1991) , EHVl (Barlow et al., 1994) RING1 (Lovering et al., 1993) and BMll (Haupt et al., 1991; van Lohuizen et al., 1991) . tionated hypotonic lysates of HeLa cells into soluble (S-100) and high salt (0.42 M KCI) extracted nuclear fractions (Dignam et al., 1983) , which were then subjected to gel exclusion chromatography.
Fractions were analyzed by immunoblotting for the presence of CDK7, cyclin H, ~36, and the TFIIH polypeptide ~62. Fractionation of the nuclear extract ( Figure 3A ) resulted in a major peak of the three CAK subunits at -650 kDa (fractions 31-33), which coincided exactly with the peak of ~62. A second, minor peak of CDK7, cyclin H, and p36 immunoreactivity appeared at -175-200 kDa (fractions 41-45), with no corresponding peak of ~62. We also consistently observed a trail of both CDK7 and cyclin H, apparently unassociated with ~36, at lower apparent molecular weights (fractions 47-49). In the S-100, the situation was reversed ( Figure  3B ). The three CAK components were predominantly in the lower molecular weight form (fractions [41] [42] [43] [44] [45] (A) CAKextracted from nuclei is in a -650 kDaTFIIH-containing complex. HeLa nuclear extract was subjected to gel filtration chromatography on Superdex 200. Alternate fractions were analyzed by immunoblotting with antibodies to the TFIIH subunit ~62, CDK7, cyclin H, and ~36. Positions of molecular weight standard proteins thyroglobulin (669 kDa), ferritin (440 kDa), aldolase (158 kDa), BSA (67 kDa), ovalbumin (45 kDa), and cytochrome C (12 kDa) are indicated at top. (B) Soluble CAK is in a -175 kDa complex. HeLa S-l 00 was analyzed by gel filtration, exactly as in (A). Each run of the sizing column represented approximately equal numbers of cells. (C) Subunit composition of distinct CAK complexes. We subjected the -650 kDa CAK-containing complex derived from the nuclear extract (lanes 2 and 5) and the -175 kDa complex isolated from the S-100 (lanes 3 and 6) to anti-cyclin H immunoaffinity chromatography.
Alkaline eluates from the antibody column were analyzed by immunoblotting (lanes l-3) with antibodies against ~62, CDK7, cyclin H, and ~36, and by silver staining (lanes 4-6). A fraction of HeLa CAK purified through the HiTrap Q step minor peak of the three CAK polypeptides, again at -650 kDa (fractions 31-33). The two major CAK-containing complexes appeared to be nearly equally abundant, on the basis of comparisons of the immunoblots. CDK7 has been shown to be predominantly nuclear in vivo ; the smaller form of the enzyme presumably represented a soluble intranuclear pool that diffused out of nuclei during hypotonic lysis.
To compare the subunit compositions of the two CAKcontaining complexes, we subjected both fractions to anticyclin H immunoaffinity chromatography.
Both forms bound to the antibody column, as measured by depletion of cyclin H in the flowthrough, although depletion was incomplete for the nuclear extract-derived material (data not shown). In both cases, alkaline elution resulted in recovery of CDK7, cyclin H, and p36 immunoreactivity (Figure 3C, lanes 2 and 3) . Upon chromatography of the high molecular weight fraction, the TFIIH subunit p62 was also retained and eluted with the CAK components (lane 2) confirming that CAK in the nuclear extract was associated with TFIIH. In contrast, p62 was absent from the eluate of the column loaded with -175 kDa CAK (lane 3) and from a partially purified CAK fraction derived from HeLa S-100 by conventional chromatographies (lane 1; Fisher and Morgan, 1994) . In addition, two other TFIIH components, ERCC2 and ERCCS, both copurified with nuclear extract-derived CAK, but not with CAK from the soluble S-l 00 (data not shown). Moreover, analysis by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and silver staining of the anti-cyclin H-bound fraction derived from the S-100 revealed the three major CAK polypeptides, CDK7, cyclin H, and ~36, in apparent 1 :l :l stoichiometry ( Figure 3C , lane 6). Similar analysis of the anti-cyclin H eluate derived from nuclear extract revealed a similar pattern, but with several (-10) additional bands, possibly representing the other TFIIH subunits ( Figure 3C , lane 5).
The presence of p36 in both complexes suggested that the basic functional unit of CAK, whether free or complexed in TFIIH, is a trimer comprising CDK7, cyclin H, and ~36. Direct evidence for association between p36 and TFIIH was obtained by subjecting the -650 kDa CAK-TFIIH complex to anti-p36 immunoaffinity chromatography ( Figure 3D ). Both p36 and p62 were retained on the antibody column and eluted with high pH (lanes 4 and 5), as were CDK7, cyclin H, ERCC2, and ERCCB (data not shown). A control column lacking antibody did not bind any of the CAK or TFIIH subunits (data not shown).
Reconstitution
of Three-Subunit CAK In Vitro To study the novel CAK-associated polypeptide and its interactions with the two previously identified subunits, CDK7 and cyclin H, we constructed baculoviruses encoding p36 with either an amino-terminal hexahistidine tag (p36-His) or a carboxy-terminal hemagglutinin epitope tag (p36-HA), as well as the untagged protein. All three proteins were expressed in infected SF9 cells, and the untagged protein migrated in SDS-PAGE near the position of the authentic p36 in highly purified CAK fractions (data not shown).
When a lysate containing p36-HA was incubated with pure recombinant CDK7 and cyclin H, active CAK could be immunoprecipitated with the monoclonal antibody 12CA5, which recognizes the HA epitope tag ( Figure 4A . In a separate experiment, a lysate containing -1 ng of p36-HA was incubated with pure CDK7 (1 ng, lanes 9 and 12) pure cyclin H (1 kg, lanes 10 and 13) or both (1 trg each, lanes 11 and 14). MAb 12CA5 immunoprecipitates were analyzed by immunoblotting with antibodies to cyclin H (lanes l-l 1, arrow at left) or to CDK7 (lanes 12-14, arrow at right). (C) p36 stimulates CAK activity. Duplicate immunoprecipitates were prepared as described in (B) (lanes l-7) and tested for the ability to phosphorylate CDK2-cyclin A. The position of CDK2 phosphorylated at T160 is indicated at left, as are the additional proteins labeled in the reaction: cyclin A, CDK7. and either p36-His or cvclin H (which comiarate). Controls were as follows: CDK7-HA without other proteins (lane 6) and with the addition of 1.2 ng of pure p36-His, but.without cyclin H (lane 9).
three-subunit CAKcan be reconstituted in vitro with CDK7, cyclin H, and p36-HA.
We attempted to purify CAK complexes both with and without ~36, in order to detect a role for the novel subunit in modulating enzymatic activity or substrate specificity. A mixture of three crude insect cell lysates (containing CDK7, p36-HA, and a histidine-tagged cyclin H) was subjected to cobalt affinity chromatography followed by HiTrap Q anion exchange chromatography and Superose 12 gel exclusion chromatography.
Precise copurification of all three subunits at the last step indicated formation cf a stable complex, which migrated at a position consistent with a globular protein of -175-200 kDa, coincident with the major peak of soluble CAK from HeLa cells (data not shown). In contrast, no two-subunit complex could be recovered by the same purification scheme starting with a mixture of lysates containing CDK7 and cyclin H-His (data not shown).
p36 Is a CAK Assembly Factor To investigate further the effect of p36 on CDK7-cyclin H complex formation, we measured the amounts of cyclin H that coimmunoprecipitated with HA-tagged CDK7 both in the absence (Figure 46 , lanes 1 and 6) or presence (in increasing amounts, lanes 2-7) of pure p36-His. The novel CAK subunit enhanced CDK7-cyclin H binding approximately 5-fold. Duplicate immunoprecipitates were assayed for CAK activity, measured as the ability to phosphorylate CDK2 ( Figure 4C ). The enhancement of CDK7-cyclin H binding by p36-His correlated with a 5 to lo-fold stimulation of enzymatic activity; stimulation of CAK activity was saturated at a p36-His:CDK7 ratio of -2:l (data not shown). We detected minimal binary complex formation between p36-HA and cyclin H in the absence of CDK7 ( Figure 4B , lane IO), and between p36-HA and CDK7 in the absence of cyclin H (lane 12). When all three components were present, coprecipitation of both cyclin H (lane 11) and CDK7 (lane 14) was readily detected.
The coimmunoprecipitation results suggested that p36 promotes stable binding of CDK7 and cyclin H. When CDK7-and cyclin H-containing lysates were mixed and subjected to gel exclusion chromatography ( Figure 5A ), both proteins migrated near their monomeric positions (-40-50 kDa), but were shifted slightly toward an intermediate position, indicating that CDK7 and cyclin H interact to some extent in the absence of ~36. The peaks were consistently offset by one fraction, however, suggesting unstable complex formation, with significant dissociation during chromatography.
Addition of p36-HA-containing lysate caused a dramatic shift in the migration of all three proteins, to a position consistent with a molecular weight of 175-200 kDa( Figure 5B ), and coincident with the apparent size of authentic CAK purified from HeLa S-100 (see Figure 3 ; data not shown). In addition to the increased apparent size, there was precise comigration of all three CAK components, indicating stable complex formation. Similar results were obtained with highly purified fractions of p36-His (-90% pure), cyclin H (>95% pure), and CDK7 (-90% pure), all at final concentrations prior to chromatography of 1 PM each (data not shown). Thus, p36 is a novel CDK7-cyclin H assembly-promoting factor.
p36 Binding Bypasses the Requirement for T170 In Vitro and In Vivo We previously reported the reconstitution of active CAK with CDK7 and cyclin H alone (Makela et al., 1994) . These studies suggested the existenceof p36-independent pathwaysforCAKassembly in both mammalian cells and budding yeast and implicated an amino acid residue, T170, known to be phosphorylated in vivo (Labbe et al., 1994; Poon et al., 1994) in mediating that assembly.
To test whether formation of a stable three-subunit complex depended on T170, we performed gel filtration analysis of two-and three-component mixtures containing CDK7-HA bearing a T170A mutation. When the mutant CDK7-HA(T170A) was incubated with pure cyclin H prior to Superose 12 chromatography ( Figure 6A ), both subunits shifted to a position intermediate between their monomeric forms, again indicating some association. However, when asimilarmixturewassubjectedtochromatography on a different resin, Superdex 75, the two subunits largely separated (data not shown), suggesting that the complexes were unstable. When CDK7-HA(T170A) was incubated with pure cyclin H and pure p36-His prior to chromatography, stable three-subunit complexes formed, and they migrated with the same apparent size as did wild-type complexes ( Figure 6B ; compare with Figure 5B ). Cyclin H appeared to be in excess in this experiment, as a significant fraction remained at its monomeric position (fraction 29). However, both CDK7-HA(T170A) and p36-His shifted to the larger size (fractions 23 and 24). We next compared the amounts of cyclin H that coimmunoprecipitated with CDK7-HA(T170A) in the absence ( Figure  6C , lane 1) or presence (lane 2) of pure p36-His. Again, p36 caused an approximate 5-fold enhancement of CDK7-cyclin H association. In fact, cyclin H binding bythe mutant CDK7 in the presence of p36 was indistinguishable from that of wild-type CDK7 (data not shown). Remarkably, the mutant trimeric complex was also as active as the wild-type complex in phosphorylating CDK2 ( Figure 6C , lane 4). Thus, p36 bypassed the requirement for T170 in assembly of stable, active CDK7-cyclin H complexes in vitro.
That p36 can also circumvent the T170 requirement in vivo was shown by transient expression in COS cells of either wild-type or T170A mutant forms of CDK7-HA together with cyclin H, in either the presence or the absence of p36 ( Figure 6D ). CDK7-HA-containing complexes were immunoprecipitated and analyzed by immunoblotting for coprecipitating cyclin H. Wild-type CDK7 bound comparable amounts of cyclin H in the absence (lane 2) or presence (lane 3) of ~36. The T170A mutant, in contrast, showed a marked defect in cyclin H binding in the absence of p36 (lane 4; compare with wild type, lane 2). The defect was completely overcome by the coexpression of p36 (lane 5). The results with the mutant CDK7 suggest that p36 levels are limiting for assembly of trimeric CAK complexes in COS cells. Moreover, the lack of a dramatic effect of p36 overexpression on assembly of wild-type CDK7-cyclin H complexes implies the existence of a p36-independent, T170-dependent CAK assembly pathway.
An Alternative CAK Assembly Pathway Requires an Activating Kinase Mammalian CDK7 is phosphorylated in vivo at two major sites: T170 and S164 (P. J. and D. 0. M., unpublished data). Because the S164 residue is in the context of a perfect CDC2/CDK2 consensus phosphorylation site (Labbe et al., 1994; Poon et al., 1994) , we tested the ability of pure activated CDKP-cyclin A and CDC2-cyclin B complexes to phosphorylate CDK7 in vitro. Surprisingly, both CDKs appeared to phosphorylate CDK7 with astoichiometry exceeding one mole of phosphate per mole of protein; tryptic phosphopeptide mapping revealed efficient phosphorylation of both S164 and T170 when CDK7 was incubated with either CDK2-cyclin A or CDC2-cyclin B (R. P. F. and D. 0. M., unpublished data). It is not clear whether CDKs phosphorylate T170 directly or stimulate autophosphorylation of Ti 70, perhaps by phosphorylating S164. In either case, these results raised the possibility of a potential positive feedback loop governing the CDK activation cycle (see Discussion); moreover, they allowed us to examine directly the effect of T170 phosphorylation on CAK assembly in vitro.
We incubated lysates containing CDK7-HA with pure cyclin H in the presence of Mg-ATP, in the absence or presence of active CDKP-cyclin A complexes, and then subjected the mixtures to gel exclusion chromatography ( Figure 7A ). CDKP-cyclin A treatment of wild-type CDK7 caused both CDK7 and cyclin H to shift quantitatively to an apparent size of -70 kDa (second panel from top, fraction 26), indicating the formation of a stable binary complex containing the -40 kDa CDK7-HA and the 37 kDa cyclin H subunits. The shift was dependent on T170, as CDK2-cyclin A treatment had no effect on the migration of either CDK7 or cyclin H in reactions containing the T170A mutant ( Figure 7A, bottom) . Stabilization of the binary CDK7-cyclin H complex by CDKP-cyclin A was accompanied by significant CAK activation, as shown by the recovery of active CAK after immunoprecipitation of column fractions (data not shown).
To confirm that CDKP-cyclin A could function as a CAKactivating kinase (CAKAK) in vitro, we analyzed its effects on CDK7-cyclin H complex formation ( Figure 76 ) and CAK activation ( Figure 7C ) in duplicate immunoprecipitations. In the absence of p36or CDK2-cyclin A (lanes l), wild-type CDK7-HA bound cyclin H weakly, and a low level of CAK activity was recovered in the immunoprecipitate. Treatment with active CDKP-cyclin A prior to immunoprecipitation caused a dramatic increase in CDK7-cyclin H association ( Figure 78 , lane 2) and a lo-fold stimulation of recovered CAK activity ( Figure 7C , lane 2). Addition of pure p36 to the reaction caused a similar stimulation of both binding ( Figure 7B , lane 3) and activation ( Figure  7C , lane 3) even in the absence of CDK2-cyclin A. When both p36 and CDK2-cyclin A were present, still higher levels of bound cyclin H (Figure 78 , lane 4) and CAK activity ( Figure 7C , lane 4) were immunoprecipitated; however, the effects were less than completely additive (data not shown). Mutation of T170 to alanine completely abolished the response to CDKP-cyclin A (Figures 78 and 7C ; compare lanes 5 and 6), while the p36-dependent assembly/ activation pathway remained intact (Figures 78 and 7C , lanes 7). In contrast, mutation of S164 to alanine did not prevent CDKP-dependent assembly and activation in the absence of p36 (Figures 78 and 7C ; compare lanes 9 and 10). The S164A mutant showed somewhat reduced activity compared with the wild-type enzyme ( Figure 7C ; compare lanes 2 and lo), raising the possibility that the phosphorylation of S164 also contributes to activation.
Discussion
A Novel Structure for a Cyclin-Dependent Kinase We have cloned and characterized a novel CAK subunit that promotesassemblyof CDK7 and cyclin H and remains tightly associated with the CDK-cyclin complex. Thus, the basic functional unit of CAK is a unique heterotrimeric CDK-cyclin-assembly factor complex. In support of this idea are previous studies Makela et al., 1994 ) that show stoichiometric association of CDK7 with cyclin H and another protein of 36 kDa. The 36 kDa protein observed by Tassan et al. (1994) has recently been identified as the human homolog of the mouse p36 protein identified in the present work and has also been shown to promote CDK7-cyclin H assembly in vitro (Tassan et al., 1995) .
The involvement of an accessory protein in assembly of CDK-cyclin complexes is novel; however, a similar mechanism may underly the function of the yeast cell cycle regulator Cdc37p. In yeast bearing a temperaturesensitive Cdc37p, there is a defect in the assembly of Cdc28p-cyclin complexes (Gerber et al., 1995) . Comparison of the amino acid sequences of p36 and Cdc37p of S. cerevisiae reveals no homology, however. A positive factor may also be required for the assembly of mammalian CDK4 and its partners, the D-type cyclins, into functional complexes . It will be of interest to know whether p36-like proteins are involved in the assembly of other CDK-cyclin complexes, or indeed whether the function of p36 is strictly limited to the CDK7-cyclin H pair.
p36 Induces a Conformational Change in the CAK Complex The CDK7-cyclin H-p36 complex assembled in vitro migrates in gel exclusion chromatography with an unexpectedly large apparent size of -200 kDa ( Figure 5 ). In contrast, binary CDK7-cyclin H complexes migrate at -70 kDa ( Figure 7A ), as expected for heterodimers of 39 kDa and 37 kDa subunits. p36 could cause complex dimerization, producing a holoenzyme with an actual mass of -220 kDa. However, we were unable to detect significant multimerization of either CDK7 or p36 when we immunoprecipitated a mixture of HA-tagged and untagged complexes with 12CA.5 antibodies under similar conditions (data not shown). Sedimentation anafyses of CAK complexes in glycerol gradients also failed to provide evidence for a higher order CAK complex; there was no significant difference between the sedimentation velocities of two-and three-subunit complexes (data not shown). Taken together, the results of gel exclusion chromatography and glycerol gradient sedimentation suggest a conformational change in the enzyme upon p36 addition, favoring its exclusion from the sizing column matrix, rather than multimerization.
An Alternative CAK Assembly Pathway and a Potential
Positive Feedback Loop The proposed function of p36 as a CAK assembly factor raised a paradox: we previously reconstituted active CAK with CDK7 and cyclin H alone . -4) , T170A(lanes5-i3), orS164A(lanes 9 and 10) forms of CDK7-HA (0.6 ng) were incubated with pure cyclin H (0.5 ng) and Mg-ATP in the absence (odd-numbered lanes) or presence (even-numbered lanes) of active CDK2-cyclinA(125 ng). Where indicated, pure p36-His (0.5 &g) was included in the incubation. Complexes were immunoprecipitated with MAb 12CA5 and analyzed by immunoblotting with anti-cyclin H antibodies (arrow at left). (C) T170 phosphorylation activates CAK, Conditions were the same as in (B); duplicate immunoprecipitates were tested for CAK activity, measured as the ability to phosphorylate CDK2-cyclin A.
yet stable binding of the two appears to require p36 in stoichiometric amounts (Figures 4 and 5) . In attempting to resolve that paradox, we uncovered an intriguing dual mechanism for CAK assembly and activation. Stable binary CDK7-cyclin H complexes can form when T170 of CDK7 is phosphorylated (Figures 6 and 7) . This mode of CDK-cyclin stabilization has a precedent: phosphorylation of an activating threonine residue by CAK is required for the assembly of CDC2 and cyclin A (Desai et al., 1995) . Are the two CAK assembly pathways (schematized in Figure 8 ) redundant mechanisms for ensuring proper CAK assembly, or do they reflect real regulatory complexity?
There is evidence for the existence of binary CDK7-cyclin H complexes in vivo; Xenopus oocyte extracts contain an -80 kDa form of CDK7 (Fesquet et al., 1993) that is apparently devoid of p36 (J. G. Crump, Ft. P. F., and D. 0. M., unpublished data). In mammalian cells, the bulk of CDK7 and cyclin H appears to be associated with p36 ( Figures 3A and 3B) , although there may be a minor population of p36-free CDK7-cyclin H complexes in the high salt nuclear extract ( Figure 3A ). We were able to purify binary CDK7-cyclin H complexes from HeLa cells , perhaps suggesting that a subpopulation of dimers exists in mammalian cells; we suspect, however, that p36 initially associated with human CAK (see Figure 3C , lane 1) was lost during purification (R. P. F. and D. 0. M., unpublished data).
Are there conditions under which T170 cannot be phosphorylated in vivo and CAK assembly is truly dependent We have elucidated two mechanisms for assembling stable, active CAK. The transient CDK7-cyclin H complex may be stabilized and activated by the assembly factor ~36, forming the ternary CAK complex that is the predominant form in mammalian cell extracts. This process canoccurin theabsenceofactivatingphosphorylation.
In thepresence of a CAKAK, the binary CDK7-cyclin H complex may be stabilized in the absence of p36 by activating threonine phosphorylation. The ability of the CAK target enzymes, the CDKs, to activate CAK in vitro by this mechanism may point to the existence of a positive activating phosphorylation feedback loop in vivo.
on p36? A definitive answer must await the identification of the CAKAK in vivo and assessments of its levels (and access to the CDK7 substrate) throughout the cell cycle. However, the evidence that CDCP and CDKP complexes are efficient CAKAKs in vitro (Figure 7 ; data not shown) raises the intriguing possibility that they perform thesame function in vivo. In that case, CDK activation could,'be governed by a positive feedback loop in which the taigets' of CAK, the CDKs, are also its activators. To initiate the loop, however, active CAK must first form in the absence of preexisting active CDKs; p36 could fulfill that requirement by bypassing the T170 phosphorylation step ( Figure  8 ) and could confer autonomy on the trimeric CAK complex. This model is highly speculative; measurements of CAK activity extracted from cells throughout the cell cycle have thus far shown little variation. At the least, the p36-independent pathway of CAK activation most likely explains the seeming discrepancies between this report and our previous results . Phosphorylation of T170 probably occurs in insect cells, producing subpopulations of CDK7 that can be activated solely by cyclin H addition (data not shown).
A Novel Function for a RING Finger Protein p36 is a novel member of a family of proteins that contain the C3HC4 zinc-binding or RING finger domain. Functional understanding of the RING finger has lagged behind its structural characterization (Barlow et al., 1994) . In several cases, metal binding has been demonstrated (Lovering et al., 1993; von Arnim and Deng, 1993) , and disruption of the C3HC4 domain has been shown to result in a loss of biological activity (Everett, 1988) . However, no physiologically relevant nucleic acid-binding or protein-protein interactions involving the domain have been discerned (Freemont, 1993; Schwabe and Klug, 1994) , owing to a lack of direct assays or known targets of these proteins. p36 may be more biochemically tractable. We may now ask whether the zinc-binding domain of p36 influences CAK assembly or conformation. p36 may contain another structure, the coiled coil, with the potential to mediate protein-protein interactions (Cohen and Parry, 1990) . Interestingly, a subfamily of RING finger proteins that contain central or carboxy-terminal coiled-coil motifs has been described (Kastner et al., 1991; Reddyet al., 1992) ; however, p36 lacks the so-called B box, an additional cysteine-and histidine-rich motif that is a hallmark of these proteins (Freemont, 1993) .
p36 in the CAK-TFIIH Complex Does p36 mediate the entry of CAK into the TFIIH holoenzyme? The novel subunit is present in both TFIIHassociated and free forms of CAK ( Figure 3 ). It is therefore surprising that a potential budding yeast homolog of p36 has recently been identified as TFB3, the 38 kDa subunit 'of core TFIIH (W. J. Feaver and R. D. Kornberg, personal communication). Core TFIIH is devoid of kinase activity and is dissociated from the constituent CDK of holoTFIIH, Kin28p (Svejstrup et al., 1994 (Svejstrup et al., , 1995 . If p36 and TFB3 are analogous proteins, it is tempting to speculate that their different behavior in vitro points to a role in recruiting or tethering CAK to the TFIIH core. Although CAK can be dissociated from TFIIH (Roy et al., 1994; Shiekhattar et al., 1995) , no reconstitution of the holoenzyme has been reported. The instability of the CDK7-cyclin H pair, lack of ~36, or both may have prevented functional reassociation. p36 contains structural motifs that may mediate interactions between CAK and the TFIIH core. With the definition of the mammalian CAK subunit composition, we may turn to the question of how the interactions of CAK with TFIIH, and perhaps with other proteins, are established, maintained, and regulated.
Experimental Procedures
Purification of Murine CAK and Tryptic Peptide Sequencing CAK was purified from mouse 3T3 ceils through the HiTrap Cl (Pharmacia) stage and transferred to polyvinylidene difluoride (PVDF) as previously described . We digested a region containing both cyclin H and p36 with trypsin. Five peptides were resolved by high pressure liquid chromatography and sequenced by Edman degradation; only one (HWTFASEEQLAR) had homology to human cyclin H. The derivation of the other peptides from a distinct protein was confirmed by cloning of a murine cyclin H cDNA. Degenerate primers based on the mouse cyclin H peptide and one from the cyclin box region of human cyclin H were used to produce a PCR product with which we isolated a nearly full-length cDNA encoding mouse cyclin H; the amino acid sequence was 95% identical to that of human cyclin H (P. J. and D. 0. M., unpublished data).
Isolation of a Mouse cDNA Encoding p36
We obtained a 451 bp PCR product by a nested two-round strategy. First, we used the sense primer 5'-GTGGAATTCGAYTAYAAYGAYT-TYYT-3' (Y = T or C), based on peptide 1, and the antisense primer 5'-GGYTGRTAYTCRTANARNGG3'(R = G or A, N = G, A, T, or C), based on peptide 4, with a mouse neuroblastoma cDNA library in plasmid pCCM6XL (Lustig et al., 1993) as template. Amplified products were used as templates for a second round with the same antisense primer, but with the sense primer5'-GARGARGTNGARGARATHGT-3' (H = A, T, or C), also based on peptide 1. We used the product to probe a mouse 3T3 cDNA library in hZAPll (Stratagene). Five positive recombinants were confirmed by secondary and tertiary screening. We sequenced both strands of one of the larger inserts.
Construction
of Baculoviruses A fragment containing the p36 coding region was inserted in transfer vector pVLCDKPNHA @' Reilly et al., 1993; Rosenblatt et al., 1993) to produce untagged ~36, or in pVLl393His (H. Jones and D. 0. M., unpublished data) to produce p36-His. To produce p36-HA, we introduced an Ncol site at the S'end of the open reading frame by oligonucleotide-directed mutagenesis (Kunkel, 1965) and cloned the resulting Ncol-Ncol fragment in pVLCDK2NHA.
Purification
of Proteins Overexpressed in Insect Cells We infected SF9 cells as previously described (Desai et al., 1992) . For purification of untagged proteins and for production of crude lysates, cells were lysed in buffer A (IO mM HEPES, 10 mM NaCI, 5 mM EDTA, 1 mM dithiothreitol [DTT] , 1 mM phenylmethylsulfonylfluoride [PMSF] , 2 uglml aprotinin, 1 ug/ml leupeptin [pH 7.41). For purification of His-tagged proteins, cells were lysed in buffer B (20 mM sodium phosphate, 20 mM NaCI, 0.5 mM DTT, 1 mM PMSF, 2 pglml aprotinin, 1 uglml leupeptin [pH 7.61). The concentrations of sodium phosphate and NaCl were then raised to 50 mM and 300 mM, respectively, and lysates were clarified by centrifugation.
Crude CDK7-or CDK7-HA-containing lysates were desalted on PDlO (Pharmacia) columns equilibrated in buffer C (25 mM HEPES, 1 mM EDTA, 10% glycerol, 1 mM EDTA, pH 7.4) plus 150 mM NaCI.
Lysates containing p36-Hiswere applied to a5 ml column of cobaltiminodiacetic acid-Sepharose 6B (Sigma), equilibrated in buffer D (50 mM sodium phosphate, 300 mM NaCI, 10% glycerol [pH 7.81). The column was washed with buffer D plus 0.5 mM DTT and developed with a linear gradient of O-300 mM imidazole in buffer D plus 0.5 mM DTT. Fractions containing p36-His were pooled, diluted It-fold with buffer C, and applied to a 1 ml HiTrap Q (Pharmacia) column equilibrated in buffer C plus 75 mM NaCI. The column was developed with a linear gradient of 75-400 mM NaCl in buffer C. p36-His-containing fractions were pooled, concentrated in acentricon 30 (Amicon), centrifuged for 30 min at 100,000 x g." in an airfuge (Beckman), and applied to a 25 ml Superose 12 (Pharmacia) column equilibrated in buffer C plus 150 mM NaCI.
Lysates contain ing CDK7 were passed over a -20 ml diethylaminoethyl (DEAE) Fast Flow (Pharmacia) column equilibrated in buffer C plus 50 mM NaCI. CDK7flowed through and was purified by sequential chromatographies on HiTrap SP (Pharmacia), Superdex 200 (Pharmacia), and ATP-agarose (Sigma). Cyclin H was purified by sequential ion exchange chromatography on S Sepharose Fast Flow (Pharmacia) and HiTrap Q, followed by gel filtration on Superose 12. Active CDK2-cyclin A complexes were prepared by mixing lysates containing roughly equal amounts of CDK2 and cyclin A, adding a fraction of HeLa cell CAK purified through the DEAE step and incubating for 30 min at room temperature in the presence of 10 mM MgCk and 1 mM ATP. The complex was then purified by sequential Mono Q (Pharmacia) and ATP-agarose chromatographies and was -80% pure (H. Jones and D. 0. M., unpublished data). In CAK activation assays ( Figures  78 and 7C ), 125 ng of the complex (final concentration: 25 nM) was used to activate 0.6 ug of CDK7 (final concentration: 300 nM).
Subcellular
Fractionation of CAK Complexes HeLa cells grown in suspension to mid-log phase were harvested by centrifugation and fractionated into a soluble high speed supernatant (S-l 00) and a high salt nuclear extract according to published methods (Dignam et al., 1983) . The nuclear extract was centrifuged for 30 min at 100,000 x g=", and both fractions were subjected to gel filtration on a 125 ml Superdex 200 column equilibrated in buffer C plus 100 mM NaCI. Fractions (1.5 ml) were analyzed by immunoblotting.
CAK Assays Activation of CDKP-cyclin A-associated
histone Hl kinase by murine CAKfractions was tested as previously described . Reconstitution of CAK in vitro was performed as described , except that where indicated, reactions contained p36-HA and untagged CDK7. Mixtures of desalted lysates, orofthe pureCAKsubunits, were incubatedfor30min at room temperature in HEPES-buffered saline (HBS; 10 mM HEPES, 150 mM NaCl [pH 7.41) plus 1 mM DTT. Complexes were immunoprecipitated with monoclonal antibody(MAb) 12CA5 (BAbCO) bound to Protein A-Sepharose (Sigma). lmmunoprecipitates were washed three timeswith HBS plus 0.1% Triton X-100 and twice with HBS plus 1 mM DTT and were assayed for the ability to phosphorylate CDKP (1 ug per assay), as previously described .
CAK Assembly Assays To measure binding of cyclin H to CDK7-HA, immunoprecipitateswere prepared as described above and analyzed by immunoblotting with anti-cyclin H antibodies. To assess pairwise binding of CDK7 and cyclin H to p36-HA, we incubated crude lysate containing -1 ug of p36-HA with 1 pg of pure CDK7, 1 ug of pure cyclin H, or both, prior to immunoprecipitation with MAb 12CA5. Duplicate blots were probed with antibodies to CDK7 and cyclin H.
Mixtures of crude lysates containing -40 ug of CDK7 (1.8 mg of total protein) and -40 ug of cyclin H-His (400 ug of total protein), with and without -40 pg of p36-HA (1.8 mg of total protein), were incubated at room temperature for 30 min in a volume of 200 1.11, centrifuged for 30 min at 100,000 x ga. in an airfuge, and applied to a 25 ml Superose 12 column equilibrated in buffer C plus 150 mM NaCI. Fractions (0.5 ml) were analyzed by immunoblotting with antibodies against CDK7, cyclin H, and the HA epitope. CDK7-HA(T170A)-containing complexes were formed by incubating a desalted lysate containing -10 ug of the mutant CDK7 with pure cyclin H (10 ug) with or without pure p36-His (10 ng) and analyzed by Superose 12 chromatography and immunoblotting with antibodies against cyclin H, ~36, and the HA epitope. To assess the effect of CDKP-cyclin A on binary CDK7-cyclih f-l complex formation, we incubated lysates containing -10 ug of CDK7-HA (wild-type or T170A) with 10 ug of pure cyclin H, with or without active CDK2-cyclin A complex (2.5 Kg), in the presence of :lO mM MgCI, and 1 mM ATP for 30 min at room temperature. Samples were then airfuged and subjected to Superose 12 chromatography.
Fractions were analyzed by immunoblotting with anti-cyclin H and MAb 12CA5 antibodies.
COS Cell Transfections
Transfection vectors encoding wild-type and T170A mutant forms of CDK7-HA, cyclin H, and p36 were constructed in vector pcDLSRa296 (Takebe et al., 1988) . Transient transfections of COS cells were performed by the DEAE-dextran method, essentially as described (Gu et al., 1990 ) using 7.5 pg of DNA (containing 2.5 ug of each CAK subunit expression construct or nonrecombinant vector) per 10 cm dish. Cells were lysed 48 hr after transfection. MAb 12CA5 immunoprecipitates were isolated from 200 ug of total protein and analyzed by immunoblotting with anti-cyclin H antibodies. In addition, 25 ug of each lysate was analyzed directly by immunoblotting with MAb 12CA5, anti-cyclin H, and anti-p36 antibodies. Expression levels of the three polypeptides varied by at most 1.5-fold between transfections (data not shown).
Immunologic
Methods Rabbit polyclonal antisera were raised against a GST-CDK7 fusion protein and purified by affinity for His-tagged C,DK7 immobilized on nitrocellulose, according to published methods (Smith and Fisher, 1984) . Antibodies to cyclin H were raised against cyclin H-His purified from bacteria and affinity-purified with the same protein coupled to Affigel 10 (Bio-Rad). Antibodies were raised to p36-His purified through the HiTrap 0 step and affinity-purifed with the same protein coupled to Affigel 15 (Bio-Rad) to prepare an immunoaffinity resin. Antibodies affinity-purified on p36-His immunoblots were used to probe Western blots. Antibodies to p62 were the gift of Drs. R. Shiekhattar, R. Drapkin, and D. Reinberg.
Anti-cyclin H or anti*36 antibodies were covalently coupled to Protein A-Sepharose (Harlow and Lane, 1988) . Fractions were passed over the affinity column three times. The column was washed with HBS plus 0.1% Triton X-100 and eluted with 100 mM triethylamine (pH 11.5) into tubes containing 1110 vol of 1 M Tris-HCI (pH 7.5). Fractions were analyzed by immunoblotting for CDK7, cyclin H, ~36, and ~62.
